Injectafer company
Webb26 juli 2013 · Injectafer® is a parenteral iron replacement product used for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to oral iron or have … WebbJanuary 2024 Injectafer Lawsuit Update. A recently filed case, Spero v. Luitpold Pharmaceuticals, Inc. ( 22-cv-04876) is a good example of a recent Injectafer lawsuit. This case was filed last month in the Eastern District of Pennsylvania by Scottsdale, Arizona woman. Spero suffers from iron deficiency anemia and was prescribed Injectafer for ...
Injectafer company
Did you know?
WebbIn the US, Ferinject® is commercialised under the brand name Injectafer®. Ferinject® has received market approval in 84 countries by the end of 2024. Educational materials … Webb25 juli 2013 · INJECTAFER (ferric carboxymaltose) Injection Company: Luitpold Pharmaceuticals, Inc. Application No.: 203565 Approval Date: 07/25/2013. Persons …
Webb8 maj 2024 · Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, reported that Injectafer® (ferric carboxymaltose injection), an iron substitute medication, has been licensed by the Food and Drug Administration (FDA) for the treatment of Iron Deficiency Anemia (IDA) in adult patients who have intolerance to oral … Webb22 mars 2024 · Injectafer (ferric carboxymaltose) is an intravenous (IV) iron replacement medication used to treat Iron Deficiency Anemia (IDA). It was designed to gradually …
WebbInjectafer is indicated for the treatment of iron deficiency anemia (IDA) in: • Adults and pediatric patients 1 year of age and older who have either intolerance to oral iron or an … WebbPeople who file Injectafer lawsuits may do so to hold Luitpold and other drug manufacturers accountable for failing to warn people about the risk of HPP. Plaintiffs may also receive compensatory damages for physical, emotional and financial losses caused by an HPP diagnosis and treatment.
WebbInjectafer is intended for single-doseonly. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. Avoid extravasation of …
WebbInjectafer can cause common side effects such as nausea, dizziness and pain. Serious side effects include high blood pressure and ... We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations. Our team includes experienced ... focus dc brunch menuWebbInjectafer ® (ferric carboxymaltose injection) is indicated for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 1 year of age and older who … focused aerial photographyWebbInjectafer is a prescription iron replacement medicine administered only by or under the supervision of your healthcare provider. Injectafer is injected into your vein to treat iron … What is Iron Deficiency Anemia - Iron Deficiency Anemia Treatment … Only your doctor can diagnose iron deficiency anemia (IDA) and he or she … Side Effects and Safety - Iron Deficiency Anemia Treatment INJECTAFER® Treatment Options for IDA - Iron Deficiency Anemia Treatment INJECTAFER® Cost Savings - Iron Deficiency Anemia Treatment INJECTAFER® Sign up to Learn More - Iron Deficiency Anemia Treatment INJECTAFER® Caregiver Resources - Iron Deficiency Anemia Treatment INJECTAFER® IDA Symptoms - Iron Deficiency Anemia Treatment INJECTAFER® focused adhdWebbI understand that Daiichi Sankyo, Inc., a parent company of American Regent, Inc. (AR), reserves the right to change or terminate any Daiichi Sankyo Access Central services (including the Injectafer Savings Program or Patient Assistance Program) at any time or to refuse to provide Injectafer to any patient under the Patient Assistance Program. focus diesel hatchbackWebbIf you have any questions, please call 1-866-4-DSI-NOW (1-866-437-4669). Our fax number is 1-888-257-4673. We are open from 8:00 AM ET – 5:00 PM ET, Monday to … focus day program incWebbThe Injectafer Savings Program helps patients being treated with Injectafer with their prescription out of pocket responsibility. Under the program, eligible insured patients … focus direct bacolod addressWebbSeveral patients filed Injectafer lawsuits against manufacturers claiming the companies knew about the risk but failed to adequately warn the public. One plaintiff suffered shortness of breath, fatigue, bone pain and weakness for three years before doctors diagnosed her with hypophosphatemia after taking Injectafer. focused advertising